Aehr Test Systems (AEHR) | Financial Analysis & Statements
Aehr Test Systems Mid-cap Technology
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: May 2025Income Metrics
Revenue
14.1M
Gross Profit
4.3M
30.32%
Operating Income
-2.3M
-16.61%
Net Income
-2.9M
-20.58%
Balance Sheet Metrics
Total Assets
148.5M
Total Liabilities
25.6M
Shareholders Equity
122.9M
Debt to Equity
0.21
Cash Flow Metrics
Operating Cash Flow
-2.8M
Free Cash Flow
-5.1M
Revenue & Profitability Trend
Quarter Income Flow
May 31, 2025
Annual Income Flow
2025
Aehr Test Systems Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 59.0M | 66.2M | 65.0M | 50.8M | 16.6M |
| Cost of Goods Sold | 35.0M | 33.7M | 32.2M | 27.2M | 10.6M |
| Gross Profit | 23.9M | 32.5M | 32.7M | 23.7M | 6.0M |
| Gross Margin % | 40.6% | 49.1% | 50.4% | 46.6% | 36.3% |
| Operating Expenses | |||||
| Research & Development | 10.5M | 8.7M | 7.1M | 5.8M | 3.7M |
| Selling, General & Administrative | 18.3M | 13.7M | 12.2M | 10.0M | 6.6M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 28.7M | 22.5M | 19.4M | 15.9M | 10.2M |
| Operating Income | -4.8M | 10.1M | 13.4M | 7.8M | -4.2M |
| Operating Margin % | -8.2% | 15.2% | 20.6% | 15.3% | -25.2% |
| Non-Operating Items | |||||
| Interest Income | 1.4M | 2.4M | 1.2M | 13.0K | - |
| Interest Expense | - | - | - | - | - |
| Other Non-Operating Income | -879.0K | -8.0K | -3.0K | 1.7M | 2.0M |
| Pre-tax Income | -4.3M | 12.5M | 14.6M | 9.5M | -2.2M |
| Income Tax | -381.0K | -20.7M | 60.0K | 91.0K | -177.0K |
| Effective Tax Rate % | 0.0% | -166.1% | 0.4% | 1.0% | 0.0% |
| Net Income | -3.9M | 33.2M | 14.6M | 9.4M | -2.0M |
| Net Margin % | -6.6% | 50.1% | 22.4% | 18.6% | -12.2% |
| Key Metrics | |||||
| EBITDA | -561.0K | 11.4M | 14.5M | 7.1M | -5.9M |
| EPS (Basic) | - | $1.15 | $0.52 | $0.36 | $-0.09 |
| EPS (Diluted) | - | $1.12 | $0.50 | $0.34 | $-0.09 |
| Basic Shares Outstanding | - | 28818000 | 27785000 | 26014000 | 23457000 |
| Diluted Shares Outstanding | - | 28818000 | 27785000 | 26014000 | 23457000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Aehr Test Systems Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 24.3M | 49.2M | 30.1M | 31.5M | 4.6M |
| Short-term Investments | - | 0 | 17.9M | 0 | - |
| Accounts Receivable | 14.2M | 9.8M | 16.6M | 12.9M | 5.2M |
| Inventory | 42.0M | 37.5M | 23.9M | 15.1M | 8.8M |
| Other Current Assets | 8.1M | 1.4M | 621.0K | 613.0K | 551.0K |
| Total Current Assets | 88.8M | 97.8M | 89.0M | 60.0M | 19.2M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 12.5M | 7.7M | 9.1M | 3.4M | 4.1M |
| Goodwill | 32.2M | - | - | - | - |
| Intangible Assets | 10.8M | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 19.7M | 21.1M | 231.0K | 201.0K | 198.0K |
| Total Non-Current Assets | 59.7M | 30.1M | 9.1M | 2.3M | 2.5M |
| Total Assets | 148.5M | 127.9M | 98.1M | 62.3M | 21.7M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 6.7M | 5.3M | 9.2M | 4.2M | 2.9M |
| Short-term Debt | 909.0K | 465.0K | 137.0K | 794.0K | 3.8M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 15.6M | 10.5M | 16.3M | 11.0M | 9.1M |
| Non-Current Liabilities | |||||
| Long-term Debt | 9.9M | 5.7M | 6.2M | 212.0K | 1.0M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 42.0K | 38.0K | 41.0K | 44.0K | 49.0K |
| Total Non-Current Liabilities | 10.0M | 5.8M | 6.2M | 325.0K | 1.2M |
| Total Liabilities | 25.6M | 16.3M | 22.5M | 11.3M | 10.2M |
| Equity | |||||
| Common Stock | 299.0K | 289.0K | 285.0K | 271.0K | 237.0K |
| Retained Earnings | -23.1M | -19.2M | -52.3M | -66.9M | -76.3M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 122.9M | 111.6M | 75.6M | 51.0M | 11.4M |
| Key Metrics | |||||
| Total Debt | 10.8M | 6.2M | 6.3M | 1.0M | 4.8M |
| Working Capital | 73.1M | 87.3M | 72.7M | 49.0M | 10.1M |
Balance Sheet Composition
Aehr Test Systems Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -3.9M | 33.2M | 14.6M | 9.4M | -2.0M |
| Depreciation & Amortization | 3.4M | 1.4M | 1.1M | 1.0M | 328.0K |
| Stock-Based Compensation | 5.2M | 2.5M | 2.7M | 3.0M | 1.1M |
| Working Capital Changes | -6.7M | -12.7M | -8.4M | -11.7M | -325.0K |
| Operating Cash Flow | -2.5M | 3.5M | 10.1M | 1.8M | -1.2M |
| Investing Activities | |||||
| Capital Expenditures | -5.0M | -749.0K | -1.4M | -416.0K | -227.0K |
| Acquisitions | -11.1M | - | - | - | - |
| Investment Purchases | 0 | 0 | -33.3M | 0 | 0 |
| Investment Sales | 0 | 18.0M | 16.0M | 0 | 0 |
| Investing Cash Flow | -16.1M | 17.3M | -18.7M | -416.0K | -227.0K |
| Financing Activities | |||||
| Share Repurchases | - | -72.0K | -2.1M | -429.0K | -20.0K |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | - | 0 | 0 |
| Debt Repayment | - | 0 | 0 | -1.4M | - |
| Financing Cash Flow | -784.0K | -1.7M | 2.7M | 20.4M | 1.4M |
| Free Cash Flow | -12.4M | 1.0M | 8.6M | 1.1M | -2.9M |
| Net Change in Cash | -19.4M | 19.1M | -5.9M | 21.7M | -3.0K |
Cash Flow Trend
Aehr Test Systems Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
19.85
Forward P/E
636.73
Price to Book
21.30
Price to Sales
66.38
PEG Ratio
0.05
Profitability Ratios
Profit Margin
-25.23%
Operating Margin
-41.01%
Return on Equity
-8.68%
Return on Assets
-6.10%
Financial Health
Current Ratio
10.97
Debt to Equity
7.22
Beta
2.29
Per Share Data
EPS (TTM)
$-0.38
Book Value per Share
$4.48
Revenue per Share
$1.50
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| AEHR | 3.0B | 19.85 | 21.30 | -8.68% | -25.23% | 7.22 |
| Lam Research | 324.8B | 54.64 | 32.75 | 65.57% | 30.22% | 44.20 |
| Applied Materials | 331.0B | 42.91 | 15.26 | 38.86% | 27.78% | 33.11 |
| Camtek | 9.4B | 188.36 | 14.55 | 8.70% | 10.23% | 86.03 |
| Ipg Photonics | 5.2B | 169.26 | 2.45 | 1.50% | 3.10% | 0.81 |
| Kulicke & Soffa | 4.4B | 5,567.00 | 5.40 | -7.19% | -9.40% | 4.48 |
Financial data is updated regularly. All figures are in the company's reporting currency.






